All material subject to strictly enforced copyright laws. © 2021 Inside P&C is part of Euromoney Institutional Investor PLC.
Accessibility | Terms & Conditions | Privacy Policy | Modern Slavery Act | Cookies |

Life science industry boosting local investment to avert supply chain risk: Willis

Warehouse interior at sunset medicine getty.jpg

Risk managers in the life science industry are focusing on opportunities for local investment because of supply chain concerns raised by the Covid-19 pandemic, according to Willis Towers Watson.

Related articles
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree